FDA Planning Disease-Specific Guidances and Endpoints for New Gene Therapies

Drug Industry Daily
A A
The FDA is planning to deliver a suite of disease-specific guidance documents next year on developing targeted gene therapies, starting with hemophilia and then more common single-gene disorders, Commissioner Scott Gottlieb told senators Thursday.

To View This Article:

Login

Subscribe To Drug Industry Daily